Sage Therapeutics (NASDAQ:SAGE) traded lower for the third straight session on Tuesday after Bank of America moved the ...

As Sage Therapeutics Inc. contemplates its path forward after rejecting a buyout offer from Biogen, its top executive ...

Sage Group reports strong growth in Q4'24 and Q1'25, driven by Sage Intacct and AI innovation. Read why SGGEF stock is a Hold ...

Tsao's report followed Sage's announcement of a weaker-than-expected sales performance for the fourth quarter. The company's collaboration revenue from Zurzuvae was $11.4 million, a slight ...

Sage Group PLC closed 11.42% below its 52-week high of £13.49, which the company achieved on February 6th.

NEW YORK, NY / ACCESS Newswire / March 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

The Sage Group plc (LON:SGE – Get Free Report)’s stock price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 1,169.95 ($15.06) and ...

Bank of America started coverage on shares of Sage Therapeutics (NASDAQ:SAGE – Free Report) in a report released on Tuesday. The brokerage issued an underperform rating and a $5.00 target price on the ...

The concepts Harris outlined in conversation with Jon Reed at the Sage Transform conference almost a year ago are now taking shape. The company has a long history of investing in AI, and is taking the ...

Sage Copilot, which was officially rolled out last year, acts as a coordinator between the deep learning-based AI models the company has long relied on for specific individual tasks, allowing for ...